While social and mobile gaming have taken off around the world, how best to monetize those games has remained something of an open question. One company, Jampp, has found a way to monetize users without forcing them to spend money, or feed them ads that they don’t want to see.
Instead, Jampp allows users in games to voluntarily view advertisements, in return for in-game currency. It’s a smart turn around on the old system: You play, and ads get in the way. With Jampp, you choose to participate, and it boosts your play.
You still have to watch an ad, fill out a survey, or download an app, but you get something for it. And, of course, the game’s developer profits as well.
Jampp’s approach is motivated by Latin America realities – as we reported, mobile gaming is a stronger trend in Latin America, while the percentage of users who pay for games is lower than in other markets.
Today, at the TNW Latin American conference in Brazil, Jampp announced that it is taking its game monetization platform, Offerwall, mobile. In short, developers of mobile games will be able to take advantage of the tools that the producers of games that run in browsers already had.
Jampp claims that games using its platform see a 30% jump in revenue. Currently, more than 50 games are using Jampp’s platform. Now that it is headed mobile, I expect that number to rise dramatically.
Also today, Jampp announced a new application, App Diaria, a daily ‘deals’ app that will show off a single free app every day. Jampp intends to use App Diaria to sell downloads, essentially, to developers. Can’t get any traction? I’ll take 10,000 downloads, please. The app itself is selling curation, that it can bring you strong free apps, to users, as the impetus for downloading it.
You can find App Diaria here, if you are so inclined.
I have a slight worry that Jampp will veer into the territory covered by Michael Arrington in his ‘ScamVille‘ series – that actions required to be completed may become ‘scammy’ and perhaps take advantage of youth. Watching an ad, however, is benign.